for the Period Ended 30 June 2024
Directors report | |
Profit and loss | |
Balance sheet | |
Additional notes | |
Balance sheet notes | |
Community Interest Report |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 30 June 2024
Directors
The directors shown below have held office during the whole of the period from
1 July 2023
to
30 June 2024
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Director
for the Period Ended
2024 | 2023 | |
---|---|---|
|
£ |
£ |
Turnover: |
|
|
Cost of sales: |
(
|
(
|
Gross profit(or loss): |
|
|
Distribution costs: |
(
|
(
|
Administrative expenses: |
(
|
(
|
Operating profit(or loss): |
|
|
Profit(or loss) before tax: |
|
|
Profit(or loss) for the financial year: |
|
|
As at
Notes | 2024 | 2023 | |
---|---|---|---|
|
£ |
£ |
|
Current assets | |||
Debtors: | 3 |
|
|
Cash at bank and in hand: |
|
|
|
Total current assets: |
|
|
|
Prepayments and accrued income: |
|
||
Creditors: amounts falling due within one year: | 4 |
(
|
|
Net current assets (liabilities): |
|
|
|
Total assets less current liabilities: |
|
|
|
Accruals and deferred income: |
(
|
(
|
|
Total net assets (liabilities): |
|
|
|
Members' funds | |||
Profit and loss account: |
|
|
|
Total members' funds: |
|
|
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 30 June 2024
Basis of measurement and preparation
Turnover policy
for the Period Ended 30 June 2024
2024 | 2023 | |
---|---|---|
Average number of employees during the period |
|
|
for the Period Ended 30 June 2024
2024 | 2023 | |
---|---|---|
£ | £ | |
Trade debtors |
|
|
Total |
|
|
for the Period Ended 30 June 2024
2023 | ||
---|---|---|
£ | ||
Trade creditors |
|
|
Total |
|
Caafi Health envisions a future where every community enjoys equitable access to health and well-being. During the financial year 2023/24, we made significant strides toward realising this vision by implementing a variety of impactful projects that directly benefited the communities we serve. Our initiatives included the continuation of the community health clinics, the launch of a Cancer Champion project in collaboration with Macmillan, the organisation of health promotion events, and proactive community outreach efforts focused on COVID-19, Flu, and HPV. These endeavours aim to dismantle the barriers that contribute to health inequity, empowering individuals to take charge of their health. At Caafi Health, we are dedicated to simplifying access to quality healthcare while simultaneously equipping individuals with the knowledge and tools to make informed lifestyle choices that enhance their well-being.
The communities impacted by health inequities, including beneficiaries, staff, volunteers, advisory board members, and commissioners, constitute the core stakeholders of Caafi Health. While we have not conducted formal consultations with these stakeholders, we actively seek and receive regular feedback on the services we offer. This ongoing dialogue has been overwhelmingly positive, reflecting the value of our programs and initiatives. We are committed to transparency and plan to share some of our findings on the Caafi Health website, ensuring that our stakeholders are informed and engaged. Our dedication to collaboration remains steadfast as we continue to forge partnerships with commissioners, community organisations, and the communities we serve. Together, we strive to advance health equity, recognising that meaningful change is achieved through collective effort and shared insights. By fostering these relationships, we aim to enhance our services and address the unique needs of the populations we support.
The total amount paid or receivable by directors in respect of qualifying services was £29,851. There were no other transactions or arrangements in connection with the remuneration of directors, or compensation for director’s loss of office, which require to be disclosed.
No transfer of assets other than for full consideration
This report was approved by the board of directors on
10 October 2024
And signed on behalf of the board by:
Name: Ash Mohamed
Status: Director